El acceso a la versión del editor puede requerir la suscripción del recurso Access to the published version may require subscription we identified a marked oxidation of key OXPHOS system subunits in Abcd1 -mouse spinal cords at presymptomatic stages. Altogether, our results illustrate some of the mechanistic intricacies by which the excess of a fatty acid targeted to peroxisomes, activates a deleterious process of oxidative damage to mitochondria, leading to a multifaceted dysfunction of this organelle. These findings may be of relevance for patient management while unveiling novel therapeutic targets for X-ALD.
INTRODUCTION
X-linked adrenoleukodystrophy (X-ALD: McKusick no. 300100) is a rare neurodegenerative disorder characterised by an inflammatory cerebral demyelination, or a progressive axonopathy in the spinal cord, causing spastic paraparesis (1) (2) (3) . With a minimum incidence of 1 in 17,000 males, X-ALD is the most frequent inherited leukodystrophy and peroxisomal disorder. It is caused by mutations in the ABCD1 gene, which encodes for an ATP-binding cassette transporter located in the peroxisomal membrane. The function of the ABCD1 protein is key in the import of very long-chain fatty acids (VLCFA, C≥22:0) and VLCFA-CoA esters into the peroxisome for degradation (4, 5) . As a consequence, the loss of the ABCD1 transporter results in the accumulation of VLCFA in most patients' organs, fibroblasts and plasma due to a lack of substrate for the VLCFA -oxidation in peroxisomes (6) (7) (8) . The main accumulated VLCFA is the hexacosanoic acid, or C26:0 that serves as a pathognomonic biomarker for the biochemical diagnosis of the disease.
The classical inactivation of the ABCD1 transporter in the mouse elicits a lateonset neurodegenerative phenotype with axonal damage in the spinal cord. The inflammatory demyelination is absent in the brain of this mouse model, which rather resembles the most frequent X-ALD phenotype, the adult adrenomyeloneuropathy or AMN (9, 10) . Signs of oxidative stress have been found in X-ALD patients' blood samples and post-mortem brains (11) (12) (13) . In this regard, we have formerly delivered evidences for an early, at presymptomatic stages occurring oxidative stress, concomitant with a bioenergetic dysfunction characterized by depleted ATP and NADH levels (14) (15) (16) . Indeed, a treatment with a mixture of antioxidants reverses oxidative damage, metabolic failure and axonal degeneration in this model, providing proof of concept on the pivotal contribution of oxidative damage to disease pathogenesis (17) (18) (19) .
The combination of a disturbance in energy homeostasis with oxidative stress, involving the mitochondria as a major player, is a common phenomenon in the physiopathogenesis of age-related neurodegenerative diseases, such as Parkinson's disease (PD), Huntington's disease (HD), Alzheimer's disease (AD) or amyotrophic lateral sclerosis (20, 21) . Of note, we and others have previously described ultrastructural abnormalities in mitochondria from neurons of Abcd1 -and Abcd2 -/-mouse spinal cords (22) and Abcd1 -adrenocortical cells (23) , consistent with observations in AMN patients (24, 25) , and peroxisomal-deficient Zellweger patients (26) and Pex5 -/-mice (27) .
In the present study, we set out to investigate mitochondrial function in the most common peroxisomal disease. We reveal a defective activity of oxidative phosphorylation (OXPHOS) in fibroblasts of X-ALD patients and in spinal cord of Abcd1 -mice at presymptomatic stages, using high-resolution respirometry. This is accompanied by the oxidation of the catalytic subunits of the mitochondrial Complex V/H + -ATP synthase, a bottleneck of oxidative phosphorylation. Furthermore, taking
advantage of the cellular model provided by patients' fibroblasts, we show that excess of C26:0 specifically impairs oxidative phosphorylation and generates mitochondrial ROS at complex I and II of the electron transport chain (ETC) in these X-ALD cells. (Fig. 1A, 1B ). In addition, the TCA cycle enzymes malate dehydrogenase (MDH) and aconitase (ACO2), the latter of which was previously detected in whole spinal cord extracts (18) , showed increased levels of oxidation. These results suggest an increase in oxidative damage in Abcd1 -spinal cords that affects key enzymes involved in mitochondrial energetic metabolism and confirmed that mitochondrial proteins are direct targets of oxidative lesions in spinal cords of the X-ALD mouse model.
RESULTS

Increased oxidation of mitochondrial proteins in spinal cords of
Oxidative phosphorylation is impaired in the spinal cord of Abcd1 -mice
Several reports indicate that the oxidation of enzymes involved in energy metabolism may result in a decrease in their activity (21) . To investigate whether OXPHOS activity is altered in X-ALD mice nervous tissue, we carried out highresolution respirometry experiments using Oroboros technology (29) . Because a previous study reported no impairment in respiratory efficacy when working with purified mitochondria from muscle of an X-ALD mouse model (30) , we sought to focus on the spinal cord, the main disease target organ, and applied an ex-vivo approach using freshly sectioned slices from presymptomatic 12-month-old Abcd1 -mice and control littermates.
Maximum oxygen consumption rates of spinal cords were assessed in the presence of the mitochondrial uncoupler carbonyl cyanide-ptrifluoromethoxyphenylhydrazone (FCCP), showing no significant differences in the activity of complexes of the ETC between both phenotypes (Fig. 2) . Inhibition of Complex III of the ETC with antimycin A almost completely abolished oxygen consumption in spinal cords of both WT and Abcd1 -mice (Fig. 2) , strongly supporting the specificity of the oxygen consumption assay in permeabilized spinal cord slices.
However, we noted that oxygen consumption after the addition of ADP, ADP + succinate or ADP + succinate + rotenone was significantly diminished in Abcd1 -mice when compared to controls (Fig. 2) . These results evidence that the activity of the H + -ATP synthase is reduced in the spinal cords of Abcd1 -mice, while activity of the respiration complexes remains conserved.
C26:0 excess induces inefficient oxidative phosphorylation in X-ALD patients' fibroblasts
To investigate whether an excess of C26:0 could be responsible for the observed mitochondrial dysfunction, we studied X-ALD patients' fibroblasts using the Seahorse Fibroblasts grown in glucose produce their ATP principally by glycolysis, largely by-passing the mitochondria. However, when the same cells are grown in glucose-free medium containing galactose, they are forced to raise the activity of OXPHOS system to produce ATP (33, 34) . Consistent with this, OSR of both control and X-ALD fibroblasts determined in galactose media, were significantly increased when compared to the rates assayed in glucose media (Fig. 3A) . Of note, control and X-ALD fibroblasts showed the same OSR when grown in glucose or galactose media (Fig.   3A ), indicating a conserved activity of OXPHOS in fibroblasts of X-ALD patients under these conditions. Moreover, no differences were observed in the normalized maximum respiratory rates between control and X-ALD fibroblasts when grown in glucose or galactose media (Fig. 3B) , indicating normal activity of the respiratory chain.
We next investigated the effect of excess of C26:0 upon OSR capacity. The OSR of control fibroblasts was not affected in both glucose and galactose media (Fig. 3A) .
Likewise, the normalized maximum respiratory rate was not affected by incubation with C26:0 (Fig. 3B) . However, C26:0-treated X-ALD fibroblasts in both glucose and galactose conditions showed a diminished activity of oxidative phosphorylation (Fig.   3A ), supporting that C26:0 excess may interfere with this specific mitochondrial activity in the patients' fibroblasts. The negative effect of C26:0 was also noted in the maximum respiratory rate in X-ALD fibroblasts when grown in galactose ( Fig. 3B ), unveiling a mitochondrial OXPHOS disruption induced by C26:0, which can be ascribed to a lower ATP synthase activity rather than lower respiratory complex activities. This is consistent with the results obtained on spinal cord slices.
We have previously observed that X-ALD fibroblasts, but not control cells, accumulate oxidative lesions to proteins in the presence of C26:0 (14) . This may suggest that OSR diminution in X-ALD fibroblasts reflects C26:0-induced severe oxidation or impairment of OXPHOS subunits provoking the drop in oxidative phosphorylation activity, as revealed in the spinal cord of Abcd1 -mice.
The uncoupling of the oxidative phosphorylation or the inhibition of complexes I and II blocks free radical production
Using the probe carboxy-H 2 DCFDA (dichlorofluorescein), which detects reactive oxygen species (ROS) of any intracellular origin, we formerly reported that an excess of C26:0 produced oxidative lesions in proteins and generated ROS (14) .
However the origin of these ROS is still unknown. Because mitochondria constitute the main source of ROS in many pathological conditions (35) , and our results indicated impaired oxidative phosphorylation, we sought to investigate whether also in X-ALD, mitochondria would represent a main source of ROS. We thus used the fluorescent dyes DHE (dihydroethidium) and MitoSOX (DHE covalently bonded to hexyl triphenylphosphonium cation), which measure intracellular and intra-mitochondrial ROS levels, respectively (36) . The levels of ROS induced by C26:0, detected using either DHE or MitoSOX probes, were similar ( As to the molecular sources of these ROS, we hypothesized that the ROS induced by C26:0 could be derived from the ETC because C26:0 somehow disrupts oxidative phosphorylation in X-ALD fibroblasts. We thus employed different compounds that disrupt the oxidative phosphorylation in control and X-ALD fibroblasts. We observed that C26:0-mediated ROS generation was prevented when the ETC flow was uncoupled by the application of carboxy-carbonyl cyanide mchlorophenylhydrazone (CCCP) (Fig. 4B ). In addition, when Complex V was inhibited by oligomycin, we also observed the prevention of C26:0-mediated ROS production ( We furthermore investigated whether the inhibition of ETC complex I by rotenone and complex II by thenoyltrifluoroacetone (TTFA) (39) could lead to an alteration in the process of C26:0-mediated ROS generation. Indeed, the joint inhibition of both complexes I and II prevented C26:0-induced ROS (Fig. 4D ). In contrast, no effects on C26:0-mediated ROS production were observed following complex III inhibition by antimycin ( Supplementary Fig. 1A ), or after the inhibition of NADPH oxidases by apocynin ( Supplementary Fig. 1B ) or the inhibition of cytochrome P450 by metyrapone ( Supplementary Fig. 1C ). Altogether, these results suggest that the C26:0-mediated ROS generation is produced by the ETC, with evidence that complexes I and II may most likely constitute the main sources of ROS upon C26:0 excess in this cellular system. These results are in agreement with the reduced OSR observed in X-ALD fibroblasts in presence of C26:0 overload, which suggests that C26:0 may hamper by an unknown mechanism the correct electron transport, facilitating electron leakage, and thus decreasing the phosphorylative respiration in these cells (Fig. 3A) .
Mitochondrial DNA is oxidised in cerebral AMN brain samples and in human fibroblasts after C26:0 exposure
Compared to nuclear DNA, mitochondrial DNA is more sensitive to mutations caused by oxidative stress because of certain factors that include a lack of protective histones and the close proximity of the mitochondrial genome to the inner mitochondrial membrane where ROS are produced (40) . To investigate whether an excess of C26:0 was able to generate mtDNA damage, we measured mtDNA oxidation levels by means of a Q-PCR approach. This is based on the fact that PCR efficiency is directly correlated to DNA oxidation levels (41), i.e. unlike that of a small DNA fragment (100 bp), the PCR efficiency of large DNA fragments (1 kb) is diminished by oxidation as deletions occur. Thus, the difference in PCR efficiency between a small and a large DNA fragment in the same locus allows us to measure the number of oxidised bases/kb. We applied this technique to samples of brain white matter of human adrenomyeloneuropathy patients, and detected increased mtDNA oxidation ratios in the affected white matter zones, which show active demyelinising plaques (Fig 5A) . To investigate whether excess of C26:0 could be responsible for this effect, we used human fibroblasts and exposed the cells to excess of C26:0, showing that both control and X-ALD cells had increased oxidation rates under these conditions (Fig. 5B) . Taken together, our data support the hypothesis that an excess of C26:0 triggers a vicious cycle of mitochondrial dysfunction that may constitute the initial steps in the neurodegenerative cascade in this disease.
DISCUSSION
Oxidative stress has been classically considered to be a common event in the neurodegenerative cascade in a variety of conditions (20, 21 A main conclusion of this study is that an excess of C26:0 disrupts the mitochondrial oxidative phosphorylation and induces the generation of free radicals at the ETC, in particular when oxido-reduction reactions take place in both complexes I
and II, at least in human fibroblasts. This in turn may lead to ETC malfunctioning and defective phosphorylative respiration evidenced in vitro in fibroblasts and ex-vivo using spinal cord slices of presymptomatic X-ALD mice. Thus, we propose that an oxidatively damaged and functionally impaired OXPHOS system may be at the sources of the neurodegenerative cascade in X-ALD. This hypothesis is consistent with previous findings studying neurodegenerative models. HD patients show a decrease in the activity of complex I in skeletal muscle, and complexes II/III and IV in the brain (44).
The activity of complex I in the substantia nigra and in the frontal cortex of PD patients is also reduced. In addition, complex IV activity is decreased in the hippocampus of AD patients (45) . Moreover, it has been demonstrated that both the inhibition of complex I by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and complex II by 3-nitropropionic acid (3-NP) in rodents leads to PD and HD, respectively (46, 47) . Our data appear to be in contrast with previous research in the field showing that respiration in isolated mitochondria from the muscle of an Abcd1 -mouse was normal (30) . As the muscle is not an organ primarily affected in the disease, one possible explanation could be that mitochondria susceptibility to VLCFA excess may vary among tissues and cell types, as the functions of these organelles may show a certain degree of heterogeneity and super-specialization among populations to adapt to specific demands and physiological functions. bioenergetic deficiency common to all these neurodegenerative diseases, and provide the rationale for exchange of therapeutic strategies among these pathologies (17) .
The precise molecular mechanisms that may drive the noxious interaction of C26:0 with mitochondria membranes and thus, the excessive mitochondria-derived ROS production in the context of X-ALD remains obscure at present. It is worth noting that the accumulation of fatty acids causes the mitochondria dysfunction underlying both common and rare conditions, such as type 2 diabetes or Refsum disease (52-54).
Because it has been shown that C26:0 can interact with a phospholipid bilayer membrane provoking a perturbation of bilayer organisation (55) (56) (57) , it is conceivable that an excess of C26:0, perhaps substituting other fatty acid species, namely polyunsaturated or monounsaturated fatty acids at the lateral chains of membrane phospholipids, could interfere with mitochondrial membrane structure and fluidity, which would disturb the proper physical interaction of OXPHOS subunits and facilitate electron leakage. These ROS would then attack fatty acid anions and produce lipid peroxides, which are highly reactive and could lead to oxidative damage to DNA, RNA and enzymes of the membrane such as the ATP synthase, or the matrix, which in turn would lead to structural damage to mitochondria. As a consequence, the inner membrane potential would decrease along with the ETC inefficiency and ROS production reported here (Fig.6 ). The elucidation of the more precise molecular mechanism should be addressed in future studies.
Taken together, our results indicate that an excess of C26:0 induces mitochondrial dysfunction in X-ALD by producing: i) mitochondrial ROS, ii) mitochondrial oxidative damage to DNA and proteins, and iii) inefficient oxidative phosphorylation (Fig. 6) . The mechanism appears to be the excessive generation of mitochondrial ROS through the chronic accumulation of C26:0, which irrevocably exacerbates mitochondrial dysfunction and leads to cell demise. In summary, our present study underscores the critical role of impaired mitochondria respiration and bioenergetics in the pathogenesis of X-ALD, which is of great importance for the clinical management of X-ALD patients. Furthermore, our results spotlight an oxidative phosphorylation impairment early in the physiopathological cascade underlying axonal degeneration and thus, pave the road for new therapeutic strategies using newgeneration antioxidants targeted to mitochondria. This may be of relevance for other neurodegenerative diseases presenting mitochondrial dysfunction and for metabolic conditions caused by the accumulation of very long-chain saturated fatty acids that are potentially toxic to this vital organelle.
MATERIAL AND METHODS
Material
The following chemicals were used: 6-carboxy-2', 7'-dichlorodihydrofluorescein diacetate, diacetoxymethyl ester (H 2 DCFDA)(Molecular 
Antibodies
The following antibodies were used for western blots: anti-DNP: dilution 1/100 (Invitrogen) as primary antibody and goat anti-rabbit IgG linked to horseradish peroxidase, dilution: 1/15000 (P0448, Dako, Glostrup, Denmark) as secondary antibody.
Cell Culture and Treatments
Control and X-ALD human fibroblasts were grown as described (14) . Control (n=7) and X-ALD human fibroblasts (n=9) were treated in medium containing fetal bovine serum (10%) for 24 hours with ethanol as control, C26:0 (50M), or an inhibitor with C26:0 (50M). The following battery of inhibitors was used: CCCP (10M), oligomycin (8M), rotenone (10nM), TTFA (500M), antimycin A (1M), apocynin (ranges from 50 to 300M, higher doses produced cell lethality) metyrapone (ranges from 50 to 500M, higher doses produced cell lethality). Experiments were carried out with cells at 80-90% of confluence, which had a number of passages ranging from 12 to 15.
Mouse breeding
The generation and genotyping of Abcd1 -mice has previously been described (9, 10, 58) . Mice used for experiments were of a pure C57BL/6J background. 
Human brain samples
Brain tissues from cerebral X-linked adrenoleukodystrophy patients and healthy male control subjects, age matched, were obtained from the Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD, USA as described in (28) . Four clinically diagnosed cALD (cerebral childhood ALD) patients and five cAMN (cerebral adrenomyeloneuropathy) patients were used. Informed written consent was obtained from all patients or their legal representatives and the local ethics committee.
Mitochondrial DNA damage
Mitochondrial DNA oxidation level was quantified by a Q-PCR approach has earlier reported (41).
Two-dimensional electrophoresis and western blotting
Redox proteomics for the identification of oxidised proteins in mice spinal cords and human fibroblasts were performed as previously described (18) .
Mitochondria enrichment
Fifty mg of fresh spinal cord is homogenized in 1mL of ice-cold sucrose buffer (sucrose 0.32M, HEPES 4mM pH7.4 and protease inhibitor cocktail) using a dounce with tight pestle and centrifuged 10min at 1000g in a refrigerated microcentrifuge. The supernatant (S1a) is kept in ice and the pellet resuspended in 750 l of ice-cold sucrose buffer, then centrifuged 10min at 1000g in a refrigerated microcentrifuge. The supernatant (S1b) is kept in ice and the pellet resuspended in 750 l of ice-cold sucrose buffer, then centrifuged 10min at 1000g in a refrigerated microcentrifuge. The supernatant (S1c) is kept in ice and the pellet discarded. S1a, S1b and S1c are centrifuged at 16000g for 10min in a refrigerated microcentrifuge. The pellet contains the mitochondrial and lysosomal enriched fractions.
Evaluation of intracellular ROS
Intracellular ROS levels were estimated using different ROS-sensitive fluorescent probes (H 2 DCFDA) excepted when it is specified in the figure legend as described (14) . H 2 DCFDA and DHE probes were used to quantify intracellular ROS.
MitoSOX™ Red (Molecular Probes) was used to quantify intra-mitochondrial ROS. All determinations were performed in 7 control and 9 X-ALD fibroblasts.
High resolution respirometry using Oroboros
Oxygen Oxygen consumption was normalized by actual protein content in the respirometer chambers.
Statistical analysis
Data are given as mean +/-SD. Significant differences were determined by 
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